GH and epidermal growth factor signaling in normal and laron syndrome fibroblasts

Endocrinology

Volumn 143, Issue 7, 2002, Pages 2610-2617

  Silva, Corinne M ^a,b   Kloth, Michael T ^a   Whatmore, Andrew J ^b   Freeth, James S ^b   Anderson, Neil ^c   Laughlin, Kristen K ^a   Huynh, Trang ^b   Woodall, Alyson J ^b   Clayton, Peter E ^b  

^a UNIVERSITY OF VIRGINIA   (United States)

^b UNIVERSITY OF MANCHESTER   (United Kingdom)

^c UNIVERSITY OF VIRGINIA HEALTH SYSTEM   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

EPIDERMAL GROWTH FACTOR; JANUS KINASE; MITOGEN ACTIVATED PROTEIN KINASE; PHOSPHATIDYLINOSITOL 3 KINASE; STAT5 PROTEIN; WORTMANNIN;

ADIPOCYTE; ARTICLE; DIMERIZATION; GROWTH HORMONE RELEASE; HORMONE RESPONSE; HUMAN; HUMAN CELL; LARON SYNDROME; PRIORITY JOURNAL; PROTEIN DOMAIN; PROTEIN EXPRESSION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION; SKIN FIBROBLAST; TARGET CELL;

EID: 0036284107     PISSN: 00137227     EISSN: None     Source Type: Journal    
DOI: 10.1210/endo.143.7.8909     Document Type: Article

References (36)

1. Genetic pituitary dwarfism with high serum concentration of growth hormone - A new inborn error of metabolism?
2. Laron syndrome: Clinical features, molecular pathology and treatment
3. Growth hormone (GH) insensitivity due to primary GH deficiency
4. Signal transduction defects in growth hormone insensitivity
5. Lessons from the genetics of Laron syndrome
6. Defects of the growth hormone receptor and their clinical implications
7. A single amino acid substitution in the exoplasmic domain of the human growth hormone (GH) receptor confers familial GH resistance (Laron syndrome) with positive GH-binding activity by abolishing receptor homodimerization
8. The D152H mutation found in growth hormone insensitivity syndrome impairs expression and function of human growth hormone receptor but is silent in rat receptor
9. Intronic mutation in the growth hormone (GH) receptor gene from a girl with Laron syndrome and extremely high serum GH binding protein: Extended phenotypic study in a very large pedigree
10. A homozygnus splice site mutation affecting the intracellular domain of the growth hormone (GH) receptor resulting in Laron syndrome with elevated GH-binding protein
11. Laron syndrome due to a post-receptor defect: Response to IGF-1 treatment
12. Human skin fibroblasts as a model of growth hormone (GH) action in GH receptor-positive Laron's syndrome
13. Activation of the signal transducers and activators of transcription signalling pathway by growth hormone (GH) in skin fibroblasts from normal and GH binding protein-positive Laron syndrome children
14. Requirement for phosphoinositide 3-OH kinase in growth hormone signalling to the mitogen-activated protein kinase and p70s6k pathways
15. Cleavage of structural proteins during the assembly of the head of bacteriophage T4
16. Human growth hormone (GH) receptor is characterized as the 134-kilodalton tyrosine-phosphorylated protein activated by GH treatment in IM-9 cells
17. Characterization and cloning of STAT5 from IM-9 cells and its activation by growth hormone
18. Wortmannin inhibits the effects of insulin and serum on the activities of glycogen synthase kinase-3 and mitogen-activated protein kinase
19. Growth hormone stimulation of the MAP kinase pathway is cell type specific
20. The role of STAT proteins in growth hormone signaling
21. STAT proteins and transcriptional responses to extracellular signals
22. STAT signalling in cell proliferation and in development
23. Differential tyrosine phosphorylation of JAK1, JAK2, and STAT1 by growth hormone and interferon-γ in IM-9 cells
24. Dimerization of the extracellular domain of the human growth hormone receptor by a single hormone molecule
25. Rational design of potent antagonists to the human growth hormone receptor
26. Stimulation of tyrosine phosphorylation in human cells by activation of the growth hormone receptor
27. Growth hormone activates mitogen-activated protein kinase and S6 kinase and promotes intracellular tyrosine phosphorylation in 3T3-F442A preadipocytes
28. Differential effects of wortmannin on growth hormone dependent signalling pathways in 3T3-F442A cells
29. Negative regulators of cytokine signal transduction
30. Negative regulation of growth hormone receptor/JAK2 signaling by signal regulatory protein alpha
31. A family of cytokine-inducible inhibitors of signaling
32. SOCS: Suppressors of cytokine signalling
33. Negative regulation of the JAK/STAT pathway
34. Mechanism of inhibition of growth hormone receptor signaling by suppressor of cytokine signaling proteins
35. The SOCS proteins: A new family of negative regulators of signal transduction
36. Growth hormone preferentially induces the rapid, transient expression of SOCS-3, a novel inhibitor of cytokine receptor signaling